Efficacy of Pain Neuroscience Education and Pre-anesthetic Assessment in Reducing Levels of Anxiety, Stress and Pain in Patients Undergoing Elective Total Abdominal Hysterectomy (ENAH Study)

CompletedNot applicableNCT05435508

View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Through this quantitative, multivariate factorial experimental parallel randomized clinical trial, the investigators analyzed the effectiveness of pre-anesthetic assessment and pain neuroscience education in reducing anxiety, stress, and pain levels in patients undergoing elective total abdominal hysterectomy.

Study details

Official title: Efficacy in Reducing Anxiety, Stress, and Pain Levels Through Preanesthetic Assessment and Pain Neuroscience Education in Patients Undergoing Elective Total Abdominal Hysterectomy: A Randomized Clinical Trial
Conditions: Pain, Chronic
Pain, Postoperative
Anesthesia
Surgery
Anxiety
Stress
Interventions: Other: Pain Neuroscience Education
Other: Usual care
Sponsor: Instituto Neurociencia Del Dolor
Collaborators: Hospital Univeristario Benemerita Universidad Autonoma de Puebla
Start date: 2024-07-01
Primary completion: 2025-02-28
Sex: Female
Age range: from 18 Years to 65 Years
Results posted: No results posted in this snapshot
Countries: Mexico
Total sites listed: 1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)

Inclusion Criteria: 1. Anesthesia Physical Classification System: I, II or III according to the classification of the American Society of Anesthesiology. 2. Acceptance of informed consent 3. Basic literacy skills sufficient to understand and complete study questionnaires. Exclusion Criteria: 1. Inability to understand study procedures or complete questionnaires. 2. Inflammatory rheumatic disease 3. Major neurological or psychiatric disease, Intellectual disability (mental retardation) or learning disorders at the premorbid level or severe language comprehension problems.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05435508